Long COVID, C diff, Candida auris: This Week's Infectious Disease Stories to Watch

Article

Stay informed about the long-term effects of COVID-19, prevention strategies for recurrent C diff, and the emerging threat of drug-resistant Candida auris.

Related Videos
Related Content
Enhancing Clostridium difficile Treatment and Prevention Efforts

Enhancing Clostridium difficile Treatment and Prevention Efforts

May 1st 2024
Article
C difficile, Antimicrobials, and the Patients Most Affected

C difficile, Antimicrobials, and the Patients Most Affected

November 23rd 2022
Podcast
Tracking the Evolution of Clostridioides difficile and Implications for Healthcare

Tracking the Evolution of Clostridioides difficile and Implications for Healthcare

April 29th 2024
Article
A Multi-Year Analysis on Antimicrobial Use on Clostridioides difficile Infection

A Multi-Year Analysis on Antimicrobial Use on Clostridioides difficile Infection

April 18th 2024
Article
Clostridioides Difficile Infection Testing Patterns and Outcomes Following Laxative Administration

Clostridioides Difficile Infection Testing Patterns and Outcomes Following Laxative Administration

April 17th 2024
Article
CDC Strategies Tested for Preventing Hospital-Onset C difficile

CDC Strategies Tested for Preventing Hospital-Onset C difficile

April 14th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.